GO
COOKIES - This website uses its own and third party cookies to help provide you with the best experience we can. By clicking “I Accept" or scrolling down this page you accept cookies.
I Accept Read Full Policy

CAT_MenuNF

Menu
Filters
_CAT_SearchNF_mobile

Search

Viroreal® Kit Sars-Cov-2 & Sars

DHUV02313
qPCR / Real Time PCR/ PCR
Ingenetix
DHUV02313x5: 500 reactions - FAM, Cy5
DHUV02313: 100 reactions - FAM, Cy5

Select Options

*Required
Add To Wish List
Request quote
Viroreal® Kit Sars-Cov-2 & Sars

Detection of RNA of SARS-CoV strains including SARS-CoV-2 and SARS-like CoV without discriminating between strains.
Detection of the virus is responsible for the disease COVID-19 (corona virus disease 2019) and also detection of the new SARS-CoV-2 variant from the UK B1.1.7 (VOC-202012/01), the Delta variant and the variant from South Africa B.1.1.529.

Background: Coronaviruses are positive single-stranded RNA viruses of the family Coronaviridae. Several different strains of coronaviruses are currently known to infect humans (HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1, MERS-CoV, SARS-CoV, SARS-CoV-2, NcoV and HCoV-EMC). Strains HCoV-229E, HCoV-NL63, HCoV-OC43, MERS-CoV and HCoV-HKU1 cause cold, upper respiratory infection, bronchiolitis and pneumonia in humans. SARS-CoV, a beta coronavirus, causes the Severe Acute Respiratory Syndrome (SARS). SARS-CoV-2 is a beta coronavirus that emerged in Wuhan, China in December 2019. The virus is responsible for the disease COVID-19 (corona virus disease 2019). Fever, cough and breathing difficulties are described as the most frequent initial symptoms, later on it can lead to pneumonia. The coronavirus spreads mainly by droplet and contact transmission. In most of the cases a mild course of infection can be observed, while more severe courses are observed in about 15%-20% of the cases, with a mortality rate of up to 3%.

Description: ViroReal® Kit SARS-CoV-2 & SARS is an in-vitro diagnostic test based on one-step reverse transcription real-time PCR. It allows rapid and sensitive detection of SARS-CoV-2 and SARS-CoV RNA in samples purified from the respiratory tract. The test is intended to cover possible future changes in the virus sequence, therefore a highly conserved region in all SARS coronavirus clusters of the N gene was chosen as target region. This approach allows universal detection of all so far known SARS-CoV strains including SARS-CoV-2 and SARS-like CoV without discriminating between strains.

Product Features:
- Amplification and detection: N gene of SARS-CoV-2 and SARS-CoV
- Transcription with thermostable MMLV Reverse Transcriptase (M-MLV)
- Contains RNase Inhibitor to block RNA degradation
- Real-time PCR with rapid hot-start Taq DNA polymerase
- ROX™ dye as passive reference
- Internal Positive Control System to exclude false-negative results
- Optimized to handle PCR inhibitors
- PCR- platforms: runs on all established standard real-time PCR- platforms
- Harmonized thermal profiles to run RNA and DNA samples simultaneously
- Available formats: kit (with reaction mix)

Related Products

Newsletter

×